They also proposed that a cutoff value exceeding 29 CL denoted established AD pathology by comparison with the phosphorylated tau/Aβ42 ratio or total tau/Aβ42 ratio of the cerebrospinal fluid. This evidence concerns the gene MAPT and Alzheimer disease.